Leo A. Barnes

2.2k total citations
14 papers, 1.6k citations indexed

About

Leo A. Barnes is a scholar working on Molecular Biology, Immunology and Allergy and Oncology. According to data from OpenAlex, Leo A. Barnes has authored 14 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 8 papers in Immunology and Allergy and 4 papers in Oncology. Recurrent topics in Leo A. Barnes's work include Cell Adhesion Molecules Research (8 papers), Angiogenesis and VEGF in Cancer (5 papers) and Platelet Disorders and Treatments (3 papers). Leo A. Barnes is often cited by papers focused on Cell Adhesion Molecules Research (8 papers), Angiogenesis and VEGF in Cancer (5 papers) and Platelet Disorders and Treatments (3 papers). Leo A. Barnes collaborates with scholars based in United States, Switzerland and India. Leo A. Barnes's co-authors include David A. Cheresh, Sara M. Weis, Jianhua Cui, Eric A. Murphy, Bharat K. Majeti, Milan Makale, Wolfgang Wrasidlo, Steven Lau, Miller Huang and David G. Jackson and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Medicine and The Journal of Cell Biology.

In The Last Decade

Leo A. Barnes

14 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Leo A. Barnes United States 11 911 469 442 264 264 14 1.6k
Anna Maria Gasparri Italy 24 1.1k 1.2× 287 0.6× 692 1.6× 171 0.6× 191 0.7× 44 2.0k
Éric Petitclerc Canada 26 1.1k 1.2× 605 1.3× 426 1.0× 186 0.7× 283 1.1× 49 2.5k
Sven Christian Germany 22 1.6k 1.7× 154 0.3× 587 1.3× 167 0.6× 201 0.8× 33 2.3k
Yasuhito Onodera Japan 25 1.3k 1.4× 310 0.7× 542 1.2× 130 0.5× 584 2.2× 46 2.1k
Antonella Zannetti Italy 27 1.1k 1.2× 189 0.4× 669 1.5× 145 0.5× 83 0.3× 66 2.0k
Jacqueline Banyard United States 14 593 0.7× 152 0.3× 309 0.7× 203 0.8× 164 0.6× 18 1.1k
Tracy Vargo-Gogola United States 21 995 1.1× 143 0.3× 914 2.1× 180 0.7× 181 0.7× 28 2.1k
Eric A. Murphy United States 11 1.2k 1.4× 121 0.3× 344 0.8× 330 1.3× 152 0.6× 20 1.9k
Miriam Benezra United States 20 1.2k 1.3× 111 0.2× 413 0.9× 343 1.3× 237 0.9× 28 2.3k
Christopher S. Gondi United States 32 1.6k 1.7× 265 0.6× 772 1.7× 154 0.6× 225 0.9× 70 2.8k

Countries citing papers authored by Leo A. Barnes

Since Specialization
Citations

This map shows the geographic impact of Leo A. Barnes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Leo A. Barnes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Leo A. Barnes more than expected).

Fields of papers citing papers by Leo A. Barnes

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Leo A. Barnes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Leo A. Barnes. The network helps show where Leo A. Barnes may publish in the future.

Co-authorship network of co-authors of Leo A. Barnes

This figure shows the co-authorship network connecting the top 25 collaborators of Leo A. Barnes. A scholar is included among the top collaborators of Leo A. Barnes based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Leo A. Barnes. Leo A. Barnes is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Zhu, Dan, Shuichan Xu, Gordafaried Deyanat‐Yazdi, et al.. (2018). Synthetic Lethal Strategy Identifies a Potent and Selective TTK and CLK1/2 Inhibitor for Treatment of Triple-Negative Breast Cancer with a Compromised G1–S Checkpoint. Molecular Cancer Therapeutics. 17(8). 1727–1738. 28 indexed citations
2.
Hagner, Patrick R., Maria Wang, Suzana S. Couto, et al.. (2014). CC-122 Has Potent Anti-Lymphoma Activity through Destruction of the Aiolos and Ikaros Transcription Factors and Induction of Interferon Response Pathways. Blood. 124(21). 3035–3035. 11 indexed citations
3.
Murphy, Eric A., Bharat K. Majeti, Rajesh Mukthavaram, et al.. (2011). Targeted Nanogels: A Versatile Platform for Drug Delivery to Tumors. Molecular Cancer Therapeutics. 10(6). 972–982. 62 indexed citations
5.
Garmy‐Susini, Barbara, Christie J. Avraamides, Michael C. Schmid, et al.. (2010). Integrin α4β1 Signaling Is Required for Lymphangiogenesis and Tumor Metastasis. Cancer Research. 70(8). 3042–3051. 134 indexed citations
6.
Desgrosellier, Jay S., Laetitia Seguin, Leo A. Barnes, et al.. (2010). Abstract 3841: An integrin αvβ3/c-Src oncogenic unit promotes anchorage independence and tumor progression. Cancer Research. 70(8_Supplement). 3841–3841. 4 indexed citations
7.
Ricono, Jill M., Miller Huang, Leo A. Barnes, et al.. (2009). Specific Cross-talk between Epidermal Growth Factor Receptor and Integrin αvβ5 Promotes Carcinoma Cell Invasion and Metastasis. Cancer Research. 69(4). 1383–1391. 116 indexed citations
8.
Shields, David J., Sherry Niessen, Eric A. Murphy, et al.. (2009). RBBP9: A tumor-associated serine hydrolase activity required for pancreatic neoplasia. Proceedings of the National Academy of Sciences. 107(5). 2189–2194. 52 indexed citations
9.
Desgrosellier, Jay S., Leo A. Barnes, David J. Shields, et al.. (2009). An integrin αvβ3–c-Src oncogenic unit promotes anchorage-independence and tumor progression. Nature Medicine. 15(10). 1163–1169. 235 indexed citations
10.
Makale, Milan, Michele McElroy, Peter O’Brien, et al.. (2009). Extended-working-distance multiphoton micromanipulation microscope for deep-penetration imaging in live mice and tissue. Journal of Biomedical Optics. 14(2). 24032–24032. 10 indexed citations
11.
Weis, Sara M., Ssang‐Taek Lim, Leo A. Barnes, et al.. (2008). Compensatory role for Pyk2 during angiogenesis in adult mice lacking endothelial cell FAK. The Journal of Cell Biology. 181(1). 43–50. 119 indexed citations
12.
Murphy, Eric A., Bharat K. Majeti, Leo A. Barnes, et al.. (2008). Nanoparticle-mediated drug delivery to tumor vasculature suppresses metastasis. Proceedings of the National Academy of Sciences. 105(27). 9343–9348. 370 indexed citations
13.
Weis, Sara M., Jeffrey N. Lindquist, Leo A. Barnes, et al.. (2006). Cooperation between VEGF and β3 integrin during cardiac vascular development. Blood. 109(5). 1962–1970. 59 indexed citations
14.
Weis, Sara M., Jianhua Cui, Leo A. Barnes, & David A. Cheresh. (2004). Endothelial barrier disruption by VEGF-mediated Src activity potentiates tumor cell extravasation and metastasis. The Journal of Cell Biology. 167(2). 223–229. 389 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026